Table 3.
Variables and groups for weighted sampling of PWUD interview participants
| Variables | Groups |
|---|---|
| Gender | Gender: TG (Transgender) |
| Gender: GNC (Gender Non-Conforming) | |
| Gender: I (Intersex) | |
| Gender: M (Male) | |
| Gender: F (Female) | |
| Age | Age: 18–29 |
| Age: 30–59 | |
| Age: 60+ | |
| Race | Race: AS (Asian) |
| Race: NH/PI (Native Hawaiian/Pacific Islander) | |
| Race: B/AA (Black/African American) | |
| Race: AI/AN (American Indian/Alaska Native) | |
| Race: WH (White) | |
| Ethnicity (Hispanic) | Ethnicity: H (Hispanic) |
| Ethnicity: NH (Non-Hispanic) | |
| Past 30 days substance use | Past 30: Stim (Stimulants) |
| Past 30: Benzo (Benzodiazepines) | |
| Past 30: 3 + subs (3 + substances) | |
| Past 30: Crack/cocaine | |
| Past 30: Rx Op (Prescription Opioid) | |
| Past 30: Meth (Methamphetamine) | |
| Past 30: Fentanyl | |
| Past 30: Heroin | |
| Past 30 days xylazine use | Past 30: Xylazine* |
| Past 30 days overdose | Past 30 OD (Overdose) |
| FTS subgroup | FTS: N-N |
| FTS: Y-Y | |
| FTS: N-Y | |
| FTS: Y-N |
*NY investigated use of xylazine test strips by PWUD participants